Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2024 11:09 ET | Source: Tevogen Bio Inc

Tevogen Bio Leadership Meets Members of U.S. Congress to Advocate for Long COVID Patients and Highlights Achievements and Assets as a Blueprint for Biotech Innovation

WARREN, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
September 19, 2023 09:00 ET | Source: GeoVax, Inc.

GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients

Data Published From Phase 2 Open-Label Study of GEO-CM04S1 ATLANTA, GA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing...
March 28, 2022 09:00 ET | Source: Physicians for Informed Consent

Physicians for Informed Consent Updates Its Information Statement About Vaccines and Immunocompromised Schoolchildren, Includes Data on COVID-19 Vaccines

NEWPORT BEACH, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent (PIC), an educational nonprofit organization focused on science and statistics, has released an update to...
February 02, 2022 10:49 ET | Source: American College of Rheumatology

Fifth Update of ACR COVID-19 Vaccine Guidance Supports Fourth Doses for High-Risk Rheumatic Disease Patients

Atlanta, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The American College of Rheumatology has issued an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and...
March 03, 2015 14:41 ET | Source: Weston A. Price Foundation

Public Health Officials Know: Recently Vaccinated Individuals Spread Disease

Washington, D.C., March 3, 2015 (GLOBE NEWSWIRE) -- Physicians and public health officials know that recently vaccinated individuals can spread disease and that contact with the immunocompromised can...
August 02, 2010 08:00 ET | Source: Inergetics, Inc.

Inergetics Receives $112,500 Purchase Order for Resurgex Select(TM) From New Marketlink Pharmaceutical Corporation

PARAMUS, N.J., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Inergetics, Inc. (OTCBB:NRTI), a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that...